Research Letter: PDF OnlyClinical Implications of Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in PregnancyMiller, Emily S. MD, MPH; Grobman, William A. MD, MBA; Sakowicz, Allie MS; Rosati, Jessica MSN, RN; Peaceman, Alan M. MDAuthor Information Northwestern University Feinberg School of Medicine, Chicago, Illinois. Corresponding author: Emily S. Miller, MD, MPH, Northwestern University Feinberg School of Medicine, Chicago, IL 60611; email: firstname.lastname@example.org. Financial Disclosure The authors did not report any potential conflicts of interest. Each author has confirmed compliance with the journal's requirements for authorship. Peer reviews and author correspondence are available at http://links.lww.com/AOG/B919. Received April 28, 2020 Received in revised form May 03, 2020 Accepted May 05, 2020 Obstetrics & Gynecology: May 19, 2020 - Volume Publish Ahead of Print - Issue - doi: 10.1097/AOG.0000000000003983 Free PAP Metrics Pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection do not seem to be identified reliably through symptom screening alone. © 2020 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.